Statin use vs. average non-HDL cholesterol levels in Togo
Togo: Statin use vs. average non-HDL cholesterol levels was 2.8 in 2018. ▲ Rising
Statin use vs. average non-HDL cholesterol levels in Togo, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
Togo recorded 2.8 for statin use vs. average non-hdl cholesterol levels in 2018. That is the highest value across all 39 years on record.
Compared with earlier readings it is up 3.7% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Togo peaked at 2.8 in 2011 and was at its lowest, 2.4, in 1980.
That places Togo 163rd out of 191 countries with data for 2018, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 2.47 | 2.4 | 2.5 | 10 |
| 1990s | 2.57 | 2.5 | 2.6 | 10 |
| 2000s | 2.67 | 2.6 | 2.7 | 10 |
| 2010s | 2.79 | 2.7 | 2.8 | 9 |
Countries ranked near Togo
- 163 Angola 2.8 compare
- 163 Burundi 2.8 compare
- 163 Cape Verde 2.8 compare
- 163 Central African Republic 2.8 compare
- 163 Chad 2.8 compare
- 163 Congo 2.8 compare
- 163 Cote d'Ivoire 2.8 compare
- 163 Democratic Republic of Congo 2.8 compare
- 163 Equatorial Guinea 2.8 compare
- 163 Eswatini 2.8 compare
- 163 Gabon 2.8 compare
- 163 Guinea-Bissau 2.8 compare
- 163 Kenya 2.8 compare
- 163 Liberia 2.8 compare
- 163 Morocco 2.8 compare
- 163 Namibia 2.8 compare
- 163 Niger 2.8 compare
- 163 Sierra Leone 2.8 compare
- 163 Uganda 2.8 compare
- 163 Zimbabwe 2.8 compare
More reference data data for Togo
- Spring temperature anomalies -0.0336 °C (2026)
- Summer temperature anomalies 0.2981 °C (2026)
- Temperature anomalies by month 1.17 °C (2026)
- Universal right to vote in practice 2 (2025)
- Autumn temperature anomalies 0.2203 °C (2025)
- Winter temperature anomalies 1.07 °C (2025)
- Consumer price index 141.25 2010 = 100 (2025)
- Universal right to vote 2 (2025)
- Competitive elections 0 (2025)
- Men's universal right to vote 1 (2025)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Togo?
- Statin use vs. average non-hdl cholesterol levels in Togo was 2.8 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Togo?
- The highest recorded value was 2.8 in 2011.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Togo?
- The lowest recorded value was 2.4 in 1980.
- How does Togo rank for statin use vs. average non-hdl cholesterol levels?
- Togo ranks 163rd out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Togo?
- Over the last ten years it is up 3.7%. The long-run trend across the full record is rising.
- Where does this Togo data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.